Journal of Pharmaceutical Research International

Obesity is one of the most challenging conditions that primary care physicians face in their profession. Despite the efforts of both patients and professionals, the condition is becoming more common. A multimodal strategy that includes food, physical exercise, and behavioral disorders is required for treatment. Dugs and surgery are also performed to receive desired results. This study summarises the data for each strategy, discusses how primary care physicians might best assist obese patients, and offers weight-loss advice.

New weight-loss techniques to treat obesity appear to have a bright future. Current medications have had limited weight reduction impacts in the overall obese population, but customized medicine will substantially impact smaller homogenous subpopulations of obese people. Multiple, complementary route drug combinations can produce double-digit weight loss in a larger, varied patient group. Furthermore, the advancement of sophisticated subcutaneous delivery technologies has paved the way for the creation of ground-breaking peptide and biologic medicines to treat obesity.

Obesity is a chronic condition that needs lifetime therapy. The BMI, waist circumference, and  other risk variables are all measured in the obesity evaluation process. Diet and exercise should be part of the management plan. Only sibutramine and orlistat are FDA-approved for long-term usage so that they can be administered to selected individuals. The only alternative that  produces persistent and considerable weight loss is bariatric surgery, provided to very obese individuals.